Literature DB >> 7831777

Intrachromosomal recombination mediated by the polyomavirus large T antigen.

S Laurent1, V Frances, M Bastin.   

Abstract

We used a spleen necrosis virus-based retroviral vector to introduce the polyomavirus replication origin into rat cells and developed a system to analyze homologous recombination events that do not reconstitute a selectable marker. Introduction of the gene coding for the polyomavirus large T antigen into the cell lines by DNA transfection promoted high-frequency recombination between the two retroviral LTRs, leading to amplification and excision of DNA sequences. To analyze homology requirements, we constructed cell lines carrying only the replication origin without exogenous repeats. Most of the cell lines sustained high-frequency recombination, presumably by undergoing homologous recombination between repetitive DNA lying in the vicinity of the integrated origin. Our results indicate that homologous recombination promoted by large T antigen does not require recombination hot spots in the viral genome other than the replication origin and they explain the cytotoxicity observed in some cell types when large T antigen is expressed in the presence of a functional origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831777     DOI: 10.1016/s0042-6822(95)80037-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Gene targeting in rat embryo fibroblasts promoted by the polyomavirus large T antigen.

Authors:  V Francès; M Bastin
Journal:  Nucleic Acids Res       Date:  1996-06-01       Impact factor: 16.971

2.  Elements of the polyomavirus replication origin required for homologous recombination mediated by large T antigen.

Authors:  S Laurent; M Bastin
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes.

Authors:  L Wiesmüller; J Cammenga; W W Deppert
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.